Literature DB >> 18555664

Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.

Tianru Jin1, I George Fantus, Jane Sun.   

Abstract

The bipartite transcription factor beta-catenin/TCF (cat/TCF) has been recognized as the major effector of the Wnt signaling pathway for more than a decade, and its over-activation has been associated with malignancy such as colon and breast cancer. Extensive examination in different cell lineages has shown that the activity of cat/TCF can be stimulated by mechanisms other than via the Wnt glycoproteins, including the stimulation of beta-cat nuclear translocation and enhanced binding of cat/TCF to the Wnt target gene promoters by insulin and insulin-like growth factor-1 (IGF-1). In addition, the heterotrimeric G proteins of the G(12) subfamily can interact with the cytoplasmic domain of cadherins, resulting in the release of the transcriptional activator beta-cat. Furthermore, certain peptide hormones may stimulate cat/TCF-mediated gene transcription via activation of their corresponding G-protein coupled receptors. Recently, the serine/threonine kinase GSK-3 has been recognized to coordinate with AMP activated protein kinase (AMPK) in phosphorylation and activation of TSC2, the major component of the tumor suppressor complex TSC1/2. Thus, Wnt activation can stimulate protein translation via GSK-3 and TSC1/2 inactivation, followed by mTOR activation. Finally, beta-cat also functions as a pivotal molecule in defense against oxidative stress via serving as a partner of forkhead box O (FOXO) transcription factors. Thus, FOXO proteins, which mainly mediate aging and stress signaling, and TCF factors, which mainly mediate developmental and proliferation signaling, compete for a limited pool of free beta-cat. Insulin and growth factors, on the other hand, control the balance between TCF- and FOXO-mediated gene transcription via phosphorylation and nuclear exclusion of FOXO proteins. These observations provide new insight to understand how Wnt, insulin/growth factors, and FOXOs are involved in versatile physiological events and the development and progression of various human diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555664     DOI: 10.1016/j.cellsig.2008.04.014

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  93 in total

1.  Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis.

Authors:  Goo Lee; Tatiana Goretsky; Elizabeth Managlia; Ramanarao Dirisina; Ajay Pal Singh; Jeffrey B Brown; Randal May; Guang-Yu Yang; Josette William Ragheb; B Mark Evers; Christopher R Weber; Jerrold R Turner; Xi C He; Rebecca B Katzman; Linheng Li; Terrence A Barrett
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

2.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

3.  CSF-1R, DAP12 and beta-catenin: a ménage à trois.

Authors:  Daniel W McVicar; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

4.  Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis.

Authors:  Chhinder P Sodhi; Xia-Hua Shi; Ward M Richardson; Zachary S Grant; Richard A Shapiro; Thomas Prindle; Maria Branca; Anthony Russo; Steven C Gribar; Congrong Ma; David J Hackam
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

5.  PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.

Authors:  I-K Kwon; R Wang; M Thangaraju; H Shuang; K Liu; R Dashwood; N Dulin; V Ganapathy; D D Browning
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

6.  A genome-wide siRNA screen identifies novel phospho-enzymes affecting Wnt/β-catenin signaling in mouse embryonic stem cells.

Authors:  Jody Groenendyk; Marek Michalak
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

7.  Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones.

Authors:  Christa Maes; Steven Goossens; Sonia Bartunkova; Benjamin Drogat; Lieve Coenegrachts; Ingrid Stockmans; Karen Moermans; Omar Nyabi; Katharina Haigh; Michael Naessens; Lieven Haenebalcke; Jan P Tuckermann; Marc Tjwa; Peter Carmeliet; Vice Mandic; Jean-Pierre David; Axel Behrens; Andras Nagy; Geert Carmeliet; Jody J Haigh
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

8.  MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation.

Authors:  Chun-Fu Hong; Yu-Ting Chou; Young-Sun Lin; Cheng-Wen Wu
Journal:  J Biol Chem       Date:  2009-05-14       Impact factor: 5.157

9.  Claudin family of proteins and cancer: an overview.

Authors:  Amar B Singh; Ashok Sharma; Punita Dhawan
Journal:  J Oncol       Date:  2010-07-08       Impact factor: 4.375

10.  Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2.

Authors:  Steve P Crampton; Beibei Wu; Edward J Park; Jai-Hyun Kim; Candice Solomon; Marian L Waterman; Christopher C W Hughes
Journal:  PLoS One       Date:  2009-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.